Press Conferences

Evolution in HIV treatment

  • 22 July 2009
    The ARTEN Study

    Results of the HIV head-to-head study ARTEN presented at IAS 2009

    Poster presentation:

    New clinical data from the ARTEN head to head study were presented by the lead author, Prof. Vicente Soriano, during the 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention in Cape Town.

    Prospective comparison of nevirapine and atazanavir/ritonavir both combined with tenofovir DF/emtricitabine in treatment-naïve HIV-1 infected patients: ARTEN study week 48 results
    (Please see Background Information; below)

    Venue: Cape Town, South Africa
    22 July 2009

    Videos with further insight:

    Please see Media Resources (below)
     

Speaker

Speaker Background information for medical media outside the US only
Prof. Vicente Soriano
Assistant Director, Dept. of Infectious Diseases, Hospital Carlos III, Madrid
Professor Vicente Soriano

Professor Vicente Soriano is assisting the National AIDS Programme in Spain and is the editor of Manual del SIDA, a reference textbook of HIV/AIDS for Spanish-speaking countries. Finally, he chairs the International Hepatitis & HIV Coinfection Panel.

Images

Images & Videos
Videos
  • Explanation from Prof. Vicente Soriano
    ARTEN study: Data presentation
    Video Professor Vicente Soriano
  • Explanation from Prof. Peter Reiss
    Why is it important to monitor lipid levels in HIV Patients?
    Video Professor Peter Reiss
  • Discussion Panel with Prof. Jürgen Rockstroh and Dr Alaan Winston
    Significance of ARTEN results
    Discussion Panel
  • Interview with Prof. Vicente Soriano
    What is the most interesting question ARTEN is posing?
    Video Professor Vicente Soriano
  • Interview with Prof. Vicente Soriano
    Which area of the data are you looking forward to most and why?
    Video Professor Vicente Soriano
  • Interview with Prof. Vicente Soriano
    Why is this important today?
    Video Professor Vicente Soriano
  • Interview with Prof. Vicente Soriano
    ARTEN is the first large-scale trial looking at Nevirapine and Truvada. Why is this important?
    Video Professor Vicente Soriano
Images
  • HIV replication
    Targeting HIV replication
  • Battle against AIDS
    Hope in the Battle against AIDS
  • Action of NNRTI's
    Mode of action of NNRTI's
  • HIV retrovirus
    HIV infection
  • HIV infection
    HIV infection

Media Contact

  • Boehringer Ingelheim GmbH
    Dr Heike Specht
    Corporate Division Communications
    55216 Ingelheim am Rhein
    Germany
     
    Phone +49 / 6132 / 77 93319
    Fax +49 / 6132 / 77 66 01
    Contact